跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZUCIEL imatinib 400mg tablet divisible blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ZUCIEL imatinib 400mg tablet divisible blister pack
Approved
STANDARD
ZUCIEL imatinib 400mg tablet divisible blister pack
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
07aff24a0d79e29d
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
07aff24a0d79e29d
Product Name
ZUCIEL imatinib 400mg tablet divisible blister pack
Artg Id
229612
Artg Name
ZUCIEL imatinib 400mg tablet blister pack
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2015-11-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
07aff24a0d79e29d
Type
Standard
Back to TGA Approvals
